KRAS and neoplasm: To better understand the mechanistic impact of deletion of wild-type Kras in the context of oncogenic KrasG12D, we transcriptionally profiled tumours arising in villin-creERT2 Krasfl/G12D mice and compared to adjacent non-transformed tissue.